Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesAssociation of metformin, elevated homocysteine and methylmalonic acid levels, and clinically worsened diabetic peripheral neuropathy
Diabetes Care, 10/30/09
Wile DJ et al. – Metformin exposure may be an iatrogenic cause for exacerbation of peripheral neuropathy in patients with type 2 diabetes. Interval screening for Cbl deficiency and systemic Cbl therapy should be considered upon initiation of, as well as during, metformin therapy to detect potential secondary causes of worsening peripheral neuropathy.
Related Articles
Prevalence and Risk Factors of Somatic and Autonomic Neuropathy in Prediabetic and Diabetic Patients
Neuroepidemiology, 11/11/09
Relevance Score: 88%
Anti-ganglioside autoantibodies in type 1 diabetes
Muscle & Nerve, 10/08/09
Relevance Score: 87%
Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study
Journal of Diabetes and its Complications, 10/12/09
Relevance Score: 82%
Intraepidermal nerve fibre density at wrist level in diabetic and non-diabetic patients
Diabetic Medicine, 11/09/09
Relevance Score: 81%
Sensory and Motor Peripheral Nerve Function and Lower-Extremity Quadriceps Strength: The Health, Aging and Body Composition Study
Journal of the American Geriatrics Society, 10/13/09
Relevance Score: 81%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Minimally invasive and conventional glucose monitoring did not differ for long-term glycaemic control in insulin-treated diabetes
Evidence-Based Medicine, 12/07/09
Sponsor
Article Search
Sponsor